New-onset Diabetes After Transplantation
📧 Sign up to get email alerts when something new happens for New-onset Diabetes After Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: The POWERED Study: Prophylaxis With Metformin to Prevent PTDM [Phase 2]
Phase 2 trial update on using metformin prophylaxis to prevent post-transplant diabetes mellitus after kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Budesonide for Liver Transplant Immune Suppression [Phase 2]
Phase 2 clinical trial evaluating budesonide for liver transplant immune suppression has completed with posted results.
-
CLINICAL_TRIALS research · 2013-06-11Clinical Trial Update: Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression [Phase 4]
Phase 4 clinical trial updating on belatacept-based immunosuppression versus standard regimens in kidney transplant patients, with a focus o…
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion [Phase 4]
Phase 4 trial evaluating safety and efficacy of converting maintenance tacrolimus to cyclosporine micro-emulsion in kidney and liver transpl…
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant [Phase 4]
Phase 4 trial evaluating conversion from tacrolimus to cyclosporine microemulsion in maintenance liver transplant patients who developed new…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.